Absci Stock News

Absci (ABSI) soars 43.5% premarket after entering into a research collaboration with Merck (MRK)

Collaboration to leverage Absci’s Deep Learning-Enabled Drug Creation™ and Bionic Protein™ technologies Collaboration to leverage Absci’s Deep Learning-Enabled Drug Creation™ and Bionic Prot

Absci Corp (NASDAQ: ABSI) is trading higher Friday after the company announced a research collaboration with Merck & Co Inc (NYSE: MRK). The collaboration will utilize Absci's AI-powered Integrated

Shares of Absci Corp. ABSI, -12.78% skyrocketed 59.1% on heavy volume in premarket trading Friday, after the biotechnology company said it could be eligible to receive up to $610 million in upfront fe

The stock price of Absci Corp (NASDAQ: ABSI) increased by over 30% pre-market today. This is why it happened.

VANCOUVER, Wash., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeuti

VANCOUVER, Washington, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the thera

VANCOUVER, Washington, Dec. 30, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therape

VANCOUVER, Wash., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeuti

Absci Corp (NASDAQ:ABSI) fell 6.8% on Thursday . The company traded as low as $9.49 and last traded at $9.49. 4,001 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 279,165 shares. The stock had previously closed at $10.18. A number of brokerages have weighed in on ABSI. []

Shares of Absci Corp (NASDAQ:ABSI) gapped up prior to trading on Tuesday . The stock had previously closed at $10.24, but opened at $10.98. Absci shares last traded at $11.13, with a volume of 20 shares changing hands. A number of analysts recently weighed in on the stock. Cowen started coverage on shares of Absci []

Vitality Biopharma (OTCMKTS:VBIO) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings. Insider & Institutional Ownership 0.3% of Vitality Biopharma shares are held by institutional investors. Comparatively, 27.3% []

Inhibitor Therapeutics (OTCMKTS:INTI) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation. Profitability This table compares Inhibitor Therapeutics and Abscis net margins, return on equity and return on []

Absci Corp (NASDAQ:ABSI)s stock price hit a new 52-week low on Monday . The company traded as low as $9.40 and last traded at $9.51, with a volume of 837 shares. The stock had previously closed at $10.56. A number of brokerages recently weighed in on ABSI. UBS Group began coverage on shares of Absci []

AIkido Pharma (NASDAQ:AIKI) and Absci (NASDAQ:ABSI) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Analyst Ratings This is a summary of current ratings and target prices for AIkido Pharma and []